New drug approvals for 2019: Synthesis and clinical applications
- PMID: 32911308
- DOI: 10.1016/j.ejmech.2020.112667
New drug approvals for 2019: Synthesis and clinical applications
Abstract
48 new drugs including 38 chemical entities (33 new chemical entities, 3 new diagnostic agents, and 2 payloads of antibody drug conjugates) and 10 biologics were approved by the U.S. Food and Drug Administration (FDA) during 2019. These marketed new drugs represent privileged structures and novel action of mechanism, and thus can be served as leads to discover new drugs with the similar biological targets and improved therapeutic efficacy. This review aims to provide an overview regarding the synthetic approaches of 33 new chemical entities approved by the FDA in 2019 and their clinical applications.
Keywords: Chemical synthesis; Clinical applications; New drugs.
Copyright © 2020 Elsevier Masson SAS. All rights reserved.
Conflict of interest statement
Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Chemical Information
